Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer
A Phase III Trial of Single Versus Fractionated Thoracic Radiation for Palliation of Symptoms in Patients With Non-Small Cell Lung Cancer
RATIONALE: Radiation therapy may relieve symptoms in patients with non-small cell lung cancer. It is not yet known which regimen of radiation therapy is most effective in relieving symptoms in patients with non-small cell lung cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of different regimens of radiation therapy to relieve symptoms in patients who have non-small cell lung cancer.
調査の概要
詳細な説明
OBJECTIVES: I. Compare the efficacy of two schedules of radiotherapy in the palliation of symptoms in patients with non-small cell lung cancer. II. Compare the toxicity of these two regimens in these patients. III. Compare the quality of life and survival of patients treated with these two regimens.
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to center, weight loss in the previous 6 months (no greater than 10% vs greater than 10%), and performance status (ECOG 0 or 1 vs 2 or 3). Patients are randomized to undergo radiotherapy as 5 fractions over 5 days or 1 fraction on 1 day. Quality of life is assessed before treatment, weekly for 5 weeks, and monthly thereafter. Patients are followed weekly for 5 weeks, then every 2 months for 1 year.
PROJECTED ACCRUAL: A total of 210 patients will be accrued for this study.
研究の種類
入学 (実際)
段階
- フェーズ 3
連絡先と場所
研究場所
-
-
Alberta
-
Calgary、Alberta、カナダ、T2N 4N2
- Tom Baker Cancer Center - Calgary
-
Edmonton、Alberta、カナダ、T6G 1Z2
- Cross Cancer Institute
-
-
British Columbia
-
Surrey、British Columbia、カナダ、V3V 1Z2
- British Columbia Cancer Agency - Fraser Valley Cancer Centre
-
Vancouver、British Columbia、カナダ、V5Z 4E6
- BC Cancer Agency
-
Victoria、British Columbia、カナダ、V8R 1J8
- British Columbia Cancer Agency - Vancouver Island Cancer Centre
-
-
Manitoba
-
Winnipeg、Manitoba、カナダ、R3E 0V9
- CancerCare Manitoba
-
-
New Brunswick
-
Moncton、New Brunswick、カナダ、E1C 8X3
- Doctor Leon Richard Oncology Centre
-
Saint John、New Brunswick、カナダ、E2L 4L2
- Saint John Regional Hospital
-
-
Newfoundland and Labrador
-
St. Johns、Newfoundland and Labrador、カナダ、A1B 3V6
- Dr. H. Bliss Murphy Cancer Centre
-
-
Nova Scotia
-
Halifax、Nova Scotia、カナダ、B3H 1V7
- Nova Scotia Cancer Centre
-
-
Ontario
-
Hamilton、Ontario、カナダ、L8V 5C2
- Cancer Care Ontario-Hamilton Regional Cancer Centre
-
Kingston、Ontario、カナダ、K7L 5P9
- Kingston Regional Cancer Centre
-
Ottawa、Ontario、カナダ、K1Y 4K7
- Ottawa Regional Cancer Centre - Civic Campus
-
Ottawa、Ontario、カナダ、K1H 8L6
- Ottawa Regional Cancer Center - General Division
-
Peterborough、Ontario、カナダ、K9H 7B6
- Peterborough Oncology Clinic
-
St. Catharines、Ontario、カナダ、L2R 5K3
- Hotel Dieu Hospital - St. Catharines
-
Sudbury、Ontario、カナダ、P3E 5J1
- Northeastern Ontario Regional Cancer Centre, Sudbury
-
Thunder Bay、Ontario、カナダ、P7A 7T1
- Northwestern Ontario Regional Cancer Centre, Thunder Bay
-
Toronto、Ontario、カナダ、M5G 2M9
- Princess Margaret Hospital
-
Windsor、Ontario、カナダ、N8W 2X3
- Cancer Care Ontario - Windsor Regional Cancer Centre
-
-
Saskatchewan
-
Saskatoon、Saskatchewan、カナダ、S7N 4H4
- Saskatoon Cancer Centre
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
DISEASE CHARACTERISTICS: Histologically or cytologically proven non-small cell lung cancer Squamous cell lung cancer Large cell lung cancer Adenocarcinoma lung cancer Mixture of above Locally advanced disease for which the patient declined aggressive treatment or that is unsuitable for aggressive curative treatment due to at least one of the following: Performance status of ECOG 2 or 3 Otherwise unexplained weight loss greater than 10% in the last 6 months Bulky disease that cannot be irradiated safely to high doses Inability to tolerate chemotherapy Cytologically positive pleural effusion OR Clinically or radiologically proven metastatic disease for which palliative chemotherapy is not planned in the first 38 days after radiotherapy No more than one brain metastasis allowed One of the following symptoms identified as the index symptom: Loss of appetite Nausea Vomiting Cough Coughing up blood Chest pain Shortness of breath Difficulty swallowing Fatigue Must have symptoms related to intrathoracic lung cancer that are amenable to radiation palliation
PATIENT CHARACTERISTICS: Age: 16 and over Performance status: ECOG 0-3 Life expectancy: Greater than 3 months Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Other: Fluent in English or French No loss of sight or other inability to complete questionnaires or diary Not pregnant No concurrent terminal illness No other active malignancy that is causing symptoms or is expected to progress in the next 3 months
PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: At least 30 days since prior chemotherapy and failed No planned chemotherapy within 38 days after study treatment Endocrine therapy: Not specified Radiotherapy: No planned laser therapy within 38 days after study treatment Surgery: At least 30 days since prior surgery and failed Other: No planned photodynamic therapy or sclerotherapy within 38 days after study treatment
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
協力者と研究者
捜査官
- スタディチェア:Andrea Bezjak, MD, MSC, FRCPC、Princess Margaret Hospital, Canada
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- SC15
- CAN-NCIC-SC15 (その他の識別子:PDQ)
- CDR0000066787 (その他の識別子:PDQ)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。